Merrimack Superior Court Consent Judgment and Dismissal Teva Global Opioid Settlement 2023-09-12
Watson Laboratories Included in Teva Opioid Settlement
Trusted by teams at
Description
Watson Laboratories, Inc. is a party to the New Hampshire opioid litigation settlement approved with Teva and affiliates. The agreement covers abatement, monetary relief, and injunctive provisions lasting up to 13 years.
Contract Details
Vendor
WATSON LABORATORIES INC
Agency
New Hampshire AG | (Domestic Violence Fatality Review Committee), NH
Contract Type
OTHER
Document Date
September 12, 2023
Contract Term
Covered by Teva Global Opioid Settlement Agreement; up to 13 years payments, relief as described
Renewal Date
2036-07-15
Renewal Info
Ongoing under national Teva settlement structure for 13 years, no automatic renewal.
More from WATSON LABORATORIES INC
Related Contracts
Issuing Agency
New Hampshire AG | (Domestic Violence Fatality Review Committee)
State
Concord, NH
More from New Hampshire AG | (Domestic Violence Fatality Review Committee)
New Hampshire Victim Services Funding RFP SFY27VS01 March 2026
State of New Hampshire v. Publicis Health, LLC Assurance of Discontinuance Feb 2024
State of New Hampshire v. Allergan Limited et al. Consent Judgment Sept 2023
Merrimack Superior Court Consent Judgment and Dismissal Teva Global Opioid Settlement 2023-09-12
Merrimack Superior Court Consent Judgment and Dismissal Teva Global Opioid Settlement 2023-09-12
Want to learn more?
Get alerts on contract renewals, new awards, and vendor activity.
Bring us your territory.
We'll show you what is forming.
See live SLED buying signals, source docs, decision-makers, contract context, and the next step into your CRM or pipeline.